KEY FEATURES
| Full Name | Tissue Factor Pathway Inhibitor |
|---|---|
| Synonym | BDCA4;Neuropilin1;NPN1;NRP 1;CD304; |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 1.56-100ng/mL |
| Sensitivity | 0.57ng/mL |
| Sample Type | serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human TFPI in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human TFPI. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human TFPI and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human TFPI, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human TFPI. You can calculate the concentration of Human TFPI in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human TFPI ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 5.03 | 12.15 | 49.07 | 5.18 | 11.92 | 48.85 |
| Standard deviation | 0.33 | 0.7 | 2.43 | 0.35 | 0.51 | 2.01 |
| CV(%) | 6.64 | 5.74 | 4.95 | 6.7 | 4.27 | 4.11 |
RECOVERY
The recovery of Human TFPI spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 92-103 | 98 |
| EDTA plasma (n=8) | 93-104 | 99 |
| Cell culture media (n=8) | 87-101 | 94 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human TFPI in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with TFPI ELISA Kits
| SERPINC1 ELISA Kit | publications with TFPI and SERPINC1 |
| FGF2 ELISA Kit | publications with TFPI and FGF2 |
| F10 ELISA Kit | publications with TFPI and F10 |
| SDC4 ELISA Kit | publications with TFPI and SDC4 |
Pathways associated with TFPI ELISA Kit
| Complement And Coagulation Cascades Pathway | Complement And Coagulation Cascades Pathway |
| Extrinsic Pathway | Extrinsic Pathway |
| Formation Of Fibrin Clot (Clotting Cascade) Pathway | Formation Of Fibrin Clot (Clotting Cascade) Pathway |
| Hemostasis Pathway | Hemostasis Pathway |
| Integrated Breast Cancer Pathway | Integrated Breast Cancer Pathway |
| Syndecan-4-mediated Signaling Events Pathway | Syndecan-4-mediated Signaling Events Pathway |
Diseases associated with TFPI ELISA Kit
| Cardiovascular Diseases | publications with TFPI and Cardiovascular Diseases |
| Inflammation | publications with TFPI and Inflammation |
| Heart Diseases | publications with TFPI and Heart Diseases |
| Venous Thrombosis | publications with TFPI and Venous Thrombosis |
| Carcinoma | publications with TFPI and Carcinoma |
| Necrosis | publications with TFPI and Necrosis |
| Disease Models, Animal | publications with TFPI and Disease Models, Animal |
| Myocardial Infarction | publications with TFPI and Myocardial Infarction |
| Kidney Diseases | publications with TFPI and Kidney Diseases |
| Pain | publications with TFPI and Pain |
Organs/Tissues associated with TFPI ELISA Kit
| Blood | publications with TFPI and Blood |
| Vascular | publications with TFPI and Vascular |
| Embryonic Tissue | publications with TFPI and Embryonic Tissue |
| Muscle | publications with TFPI and Muscle |
| Lung | publications with TFPI and Lung |
| Kidney | publications with TFPI and Kidney |
| Heart | publications with TFPI and Heart |
| Liver | publications with TFPI and Liver |
| Umbilical Cord | publications with TFPI and Umbilical Cord |
| Placenta | publications with TFPI and Placenta |